RecruitingVaccinePneumococcal Disease
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend against certain types of bacteria. We will give two different types of vaccine and evaluate the effectiveness of antibodies produced by each vaccine in killing bacteria.
Sponsor: University of Alabama at Birmingham
You may qualify if…
- ✓ Healthy adult
You may not qualify if…
- ✕ No prior history of pneumococcal vaccination
- ✕ No immunosuppressing medications or chronic diseases that affect immune function
Where it's recruiting
Alabama
Birmingham
Source: ClinicalTrials.gov · NCT07135453 · last updated 2026-05-05